Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
Publication
, Journal Article
Kutyifa, V; Beck, C; Brown, MW; Cannom, D; Daubert, J; Estes, M; Greenberg, H; Goldenberg, I; Hammes, S; Huang, D; Klein, H; Knops, R ...
Published in: Am Heart J
July 2017
Patients with diabetes mellitus, prior myocardial infarction, older age, and a relatively preserved left ventricular ejection fraction remain at risk for sudden cardiac death that is potentially amenable by the subcutaneous implantable cardioverter defibrillator with a good risk-benefit profile. The launched MADIT S-ICD study is designed to test the hypothesis that post-myocardial infarction diabetes patients with relatively preserved ejection fraction of 36%-50% will have a survival benefit from a subcutaneous implantable cardioverter defibrillator.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
July 2017
Volume
189
Start / End Page
158 / 166
Location
United States
Related Subject Headings
- United States
- Treatment Outcome
- Survival Rate
- Prospective Studies
- Myocardial Infarction
- Male
- Incidence
- Humans
- Follow-Up Studies
- Female
Citation
APA
Chicago
ICMJE
MLA
NLM
Kutyifa, V., Beck, C., Brown, M. W., Cannom, D., Daubert, J., Estes, M., … MADIT S-ICD Executive Committee, . (2017). Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol. Am Heart J, 189, 158–166. https://doi.org/10.1016/j.ahj.2017.04.014
Kutyifa, Valentina, Christopher Beck, Mary W. Brown, David Cannom, James Daubert, Mark Estes, Henry Greenberg, et al. “Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.” Am Heart J 189 (July 2017): 158–66. https://doi.org/10.1016/j.ahj.2017.04.014.
Kutyifa V, Beck C, Brown MW, Cannom D, Daubert J, Estes M, et al. Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol. Am Heart J. 2017 Jul;189:158–66.
Kutyifa, Valentina, et al. “Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.” Am Heart J, vol. 189, July 2017, pp. 158–66. Pubmed, doi:10.1016/j.ahj.2017.04.014.
Kutyifa V, Beck C, Brown MW, Cannom D, Daubert J, Estes M, Greenberg H, Goldenberg I, Hammes S, Huang D, Klein H, Knops R, Kosiborod M, Poole J, Schuger C, Singh JP, Solomon S, Wilber D, Zareba W, Moss AJ, MADIT S-ICD Executive Committee. Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol. Am Heart J. 2017 Jul;189:158–166.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
July 2017
Volume
189
Start / End Page
158 / 166
Location
United States
Related Subject Headings
- United States
- Treatment Outcome
- Survival Rate
- Prospective Studies
- Myocardial Infarction
- Male
- Incidence
- Humans
- Follow-Up Studies
- Female